Doxorubicin‐associated takotsubo cardiomyopathy in a patient with adult T‐cell leukemia/lymphoma

This case highlights the first reported association of doxorubicin with takotsubo cardiomyopathy (TC) presenting as cardiogenic shock during the first continuous infusion in a patient with adult T‐cell leukemia/lymphoma. We aim to raise awareness to recognize and distinguish between irreversible doxorubicin‐associated cardiomyopathy and reversible doxorubicin‐associated TC in patients with cancer. This case highlights the first reported association of doxorubicin with takotsubo cardiomyopathy (TC) presenting as cardiogenic shock during the first continuous infusion in a patient with adult T‐cell leukemia/lymphoma. We aim to raise awareness to recognize and distinguish between irreversible doxorubicin‐associated cardiomyopathy and reversible doxorubicin‐associated TC in patients with cancer.